Issels Integrative Immuno-Oncology February 23, 2017  

Dendritic Cell Vaccines Are Changing Cancer Treatment Focus in the U.S.

Dear Friend,

"When Angelina Jolie learned she has a breast cancer gene, we didn't know what else to do, so we cut her breasts off," Dr. Susan Love, president of the Dr. Susan Love Research Foundation, recently told USA Today. "We have to be looking for the cause. I worry that if we don't, that we're paying too much attention to the treatment, which comes with a huge cost."

Interviewed about the new U.S. push to develop a breast cancer vaccine, Dr. Love was voicing the frustration many feel about the focus of U.S. cancer research and treatment. Appearing to lag behind their European peers, U.S. cancer researchers are only now recognizing the importance of immunotherapy in treating cancer.

Jumping on the bandwagon, many U.S. university centers are exploring immunotherapy's holistic, non-toxic approach to cancer treatment and beginning to offer trials of dendritic cell vaccines. Issels already has more than half a century of clinical experience with immunotherapy and years of integrating dendritic cell vaccines into customized comprehensive treatment programs.

At the University of Pennsylvania, doctors recently began testing personalized cancer vaccines made with the patient's own immune cells. As noted in the USA Today article, in the Pennsylvania test, women with an early cancerous condition called ductal carcinoma in situ (DCIS) are being inoculated with an immunotherapy vaccine following surgical removal of breast tumors. It is hoped that the vaccination will prevent tumor recurrence; but trial participants will have to wait years before they know if the vaccine is effective.

At Issels you don't have to wait. We already have a unique track record of long-term cancer remission results using cancer vaccines in integrative immunotherapy.

Dendritic Cell Vaccines Are Changing Cancer Treatment Focus in the U.S.

Read more interesting articles on the "Issels Cancer Immunotherapy" news/blog posted every Tuesday and Thursday. Check It Out Now »

Dendritic Cell Therapy Has Been Funded by the American Cancer Society

Immunotherapy for cancer received a major boost when Dr. Ralph M. Steinman of Rockefeller University discovered the dendritic cell, which plays a vital role in the function of the immune system. Dendritic cells trigger responses in T cells, allowing them to more effectively target invading cancer cells. Along with his colleague Jules Hoffman, head of a laboratory in Strasburg, France, Dr. Beutler conducted extensive research concerning innate immunity, which is the body's first line of defense against cancer cells and other invaders.

Get the Full Story!

Issels Cancer Vaccines Offer Non-Toxic Cancer Treatment Alternative

Issels autologous cancer vaccines are prepared from the patient's own blood to be non-toxic and compatible with the patient's immune system. Our cancer vaccines work with the body's own immune system to strengthen the patient's natural immunity against cancer cells. These disease-fighting antibodies remain in the blood stream, our immune system responds and creates a powerful barrier to future exposure. Issels cancer vaccines work in much the same way. Prepared from the patient's own blood, Issels autologous cancer vaccines intensify immune system response and enhances the body's ability to fight cancer.

Get the Full Story!

Videos – What Do Patients Say About Their Experience?

Watch videos of patients who share their own experiences at the Issels clinics with you. Listen to their stories and cancer journeys.

Get the Full Story!

Learn More

Testimonials »

Treatments »

Vaccines »

Statistics »

History »

Locations »

Contact Us »

Connect With Us:

Google +

Contact Info:

Phone: 888-447-7357


Treatments | Testimonials | Contact Us